diaminoguanidine has been researched along with Diabetes Mellitus, Type 2 in 1 studies
*Diabetes Mellitus, Type 2: A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, L; Chen, Z; Ge, X; He, X; Huang, Y; Jiang, X; Lin, Z; Liu, B; Liu, T; Xu, W; Zeng, F; Zhao, C; Zhao, L; Zhu, Y | 1 |
1 other study(ies) available for diaminoguanidine and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
6,8-(1,3-Diaminoguanidine) luteolin and its Cr complex show hypoglycemic activities and alter intestinal microbiota composition in type 2 diabetes mice.
Topics: Animals; Chromium; Diabetes Mellitus, Type 2; Gastrointestinal Microbiome; Glycogen Synthase Kinase 3 beta; Guanidines; Hypoglycemic Agents; Luteolin; Mice; Organometallic Compounds; Phosphatidylinositol 3-Kinases | 2022 |